Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site




MERCK & CO., INC. (MRK)

The QuantWave forecast for MRK merck & co., inc.

MRK (Merck & Co., Inc.) is a global pharmaceutical company based in the United States. With a rich history dating back to 1891, Merck focuses on discovering, developing, manufacturing, and marketing a wide range of innovative healthcare products. They specialize in prescription medicines, vaccines, biologic therapies, animal health products, and performance materials. As a leading pharmaceutical company, Merck is committed to improving lives by addressing unmet medical needs and making healthcare more accessible worldwide.
The graph shows the results of our forecasting system for MRK. You can view historical price data with some markers indicating where our system has been signaling and where the projected targets have been achieved. This demonstrates to what extent our system's forecasts have been justified in real market conditions.

We do not display all the achieved goals on the graph, you can get detailed information about the achieved goals in the corresponding section on this page

Access the MRK Forecast by QuantWave

Stock ticker: MRK
Name: MERCK & CO., INC.
Sector: Healthcare
Investing Risk: HIGH
Forecast length: 9 days
Accuracy: 58.49 %
Average profit per target: 9.85 %


MRK Achieves Targets with Precision, as Predicted by QuantWave

Show news about the achieved forecast
Signal Date Signal Price Date Reached Price Reached Profit Direction
2022-04-2776.69 $2022-11-2298.71 $ 28.71%
2022-05-0579.96 $2022-12-14103.69 $ 29.67%
2022-05-0680.31 $2022-12-14103.69 $ 29.11%
2022-05-0979.63 $2022-12-14103.69 $ 30.22%
2022-05-1079.78 $2022-12-14103.69 $ 29.96%
2022-05-1181.04 $2022-12-14103.69 $ 27.95%
2022-05-1282.53 $2022-12-08102.36 $ 24.03%
2022-05-1382.14 $2022-12-08102.36 $ 24.61%
2022-05-1683.88 $2022-12-08102.36 $ 22.03%
2022-05-1784.5 $2022-11-28100.14 $ 18.52%
2022-05-1883.68 $2022-11-2599.27 $ 18.62%
2022-05-2585.18 $2022-12-14103.69 $ 21.73%
2022-06-0182.81 $2022-11-28100.14 $ 20.93%
2022-06-0381.69 $2022-11-2298.71 $ 20.84%
2022-06-0782.21 $2022-11-28100.14 $ 21.82%
2022-06-0881.3 $2022-11-28100.14 $ 23.18%
2022-06-1079.21 $2022-12-14103.69 $ 30.9%
2022-06-1377.23 $2022-12-14103.69 $ 34.26%
2022-06-1477.4 $2023-01-06106.75 $ 37.91%
2022-06-1577.52 $2023-01-06106.75 $ 37.7%
2022-06-1677.76 $2023-01-06106.75 $ 37.28%
2022-06-1777.51 $2023-01-06106.75 $ 37.71%
2022-06-2180.64 $2023-01-06106.75 $ 32.38%
2022-06-2384.27 $2023-01-05105.63 $ 25.34%
2022-06-2884.17 $2023-04-13108.18 $ 28.52%
2022-07-0785.2 $2023-05-02110.34 $ 29.51%
2023-07-03107.73 $2024-03-27126.69 $ 17.6%
2023-09-05101.3 $2024-01-29115.89 $ 14.4%
2024-12-2497.62 $2025-02-0686.43 $ 11.46%
2024-12-3197.65 $2025-02-0686.43 $ 11.49%
2025-03-0490.86 $2025-04-1675.7 $ 16.68%
2025-03-0792.91 $2025-05-1472.74 $ 21.71%
2025-03-1192.99 $2025-05-1472.74 $ 21.77%
2025-03-2786.73 $2025-05-1472.74 $ 16.13%

Access the MRK Forecast by QuantWave


The latest news about the achievement of forecasting results and global news about merck & co., inc.


MRKJune 19, 2025Merck KGaAs ETR:MRK Fundamentals Look Pretty Strong: Could The Market Be Wrong About the Stock?  ~1 min.

MRK Merck & Co., Inc. has recently received FDA approval to expand the use of its top-selling drug Keytruda. This news has led to positive expectations for the company's future performance....

MRKMarch 22, 2025Merck & Co., Inc. (MRK) Tops List of Dividend Contenders  ~1 min.

Merck & Co., Inc. (MRK) has been recognized as one of the top dividend contenders in the market, according to Yahoo Finance....

MRKMarch 19, 2025Merck Co. Inc. MRK: Among Dobermans of the Dow to Buy  ~1 min.

Merck Co. Inc. (MRK) has emerged as a top pick among investors looking for stable and reliable stocks....

MRKMarch 18, 2025Merck & Co. Inc. Urges Shareholders to Join Class Action  ~1 min.

Shareholders that lost money on Merck & Co. Inc. (MRK) are being urged to join a class action against the company....

MRKMarch 16, 2025Merck & Co., Inc.: A Promising Investment Opportunity with Strong Growth Potential  ~2 min.

Merck & Co., Inc., commonly known as Merck, has emerged as one of the most undervalued stocks in the US market, as indicated by leading hedge funds....

MRKMarch 15, 2025Merck & Co. MRK Opens $1B Next-Gen Vaccine Facility in Major US Expansion  ~2 min.

Merck & Co. (MRK), one of the leading pharmaceutical companies, has announced the opening of its state-of-the-art $1 billion Next-Generation Vaccine Facility....

MRKMarch 14, 2025Merck Co. Inc.: Investing in a Strong and Reliable Dividend Stock  ~2 min.

Merck & Co., Inc., commonly known as Merck, is a global healthcare company that develops and markets innovative pharmaceutical, vaccine, biologic, and animal health products....

MRKFebruary 28, 2025Merck MRK to Present Strategic Update at TD Cowen Healthcare Conference  ~2 min.

Merck & Co., Inc. (MRK) is set to present its strategic update at the upcoming TD Cowen Healthcare Conference....

MRKFebruary 27, 2025ROSEN HIGHLY RECOGNIZED INVESTOR COUNSEL Encourages Merck Co. Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action  ~1 min.

Investors of MRK Merck & Co. Inc. have been urged by ROSEN HIGHLY RECOGNIZED INVESTOR COUNSEL to seek legal representation before the critical deadline related to a securities class action....

MRKFebruary 20, 2025MRK MERCK & CO., INC.: A Promising Stock to Consider, According to Experts  ~2 min.

Merck & Co., Inc. (NYSE: MRK) has caught the attention of investors as a potential investment opportunity....




Other QuantWave offers: